Publicacións en colaboración con investigadores/as de Universidad Autónoma de Chile (18)

2024

  1. Unveiling the Significance of HLA and KIR Diversity in Underrepresented Populations

    Biomedicines, Vol. 12, Núm. 6

  2. Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases

    Best Practice and Research: Clinical Rheumatology

2023

  1. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies

    European Journal of Medicinal Chemistry, Vol. 248

  2. HLA alleles: important pieces to the COVID-19 puzzle

    Trends in Immunology

  3. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19

    HLA, Vol. 102, Núm. 6, pp. 731-739

  4. Phytochemical Analysis and Antiproliferative Activity of Ulex gallii Planch. (Fabaceae), a Medicinal Plant from Galicia (Spain)

    Molecules, Vol. 28, Núm. 1

2022

  1. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

    Molecules, Vol. 27, Núm. 3

  2. Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

    ChemMedChem, Vol. 17, Núm. 21

2021

  1. 7-Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation

    ChemMedChem, Vol. 16, Núm. 1, pp. 179-186

  2. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors

    Bioorganic Chemistry, Vol. 108

  3. Curcumin–coumarin hybrid analogues as multitarget agents in neurodegenerative disorders

    Molecules, Vol. 26, Núm. 15

2020

  1. 3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?

    Bioorganic Chemistry, Vol. 101

  2. Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents

    ChemMedChem, Vol. 15, Núm. 6, pp. 532-538

  3. Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson's disease: Synthesis, in vitro and in vivo studies

    Bioorganic Chemistry, Vol. 101

2019

  1. Design, Synthesis and Docking Calculations of Prenylated Chalcones as Selective Monoamine Oxidase B Inhibitors with Antioxidant Activity

    ChemistrySelect, Vol. 4, Núm. 26, pp. 7698-7703

  2. Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels

    Future Medicinal Chemistry, Vol. 11, Núm. 3, pp. 179-191

2017

  1. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors

    European Journal of Medicinal Chemistry, Vol. 139, pp. 1-11

  2. Synthesis and vasorelaxant and antiplatelet activities of a new series of (4-Benzylphthalazin-1-ylamino)alcohol derivatives

    Medicinal Chemistry Research, Vol. 26, Núm. 8, pp. 1682-1688